Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05657808 · ClinicalTrials.gov registry record · NA
Radicle Rest 2: A Study of Health and Wellness Products on Sleep and Health Outcomes
A NA study, sponsored by Radicle Science.
- Completed
- Registry status
- NA
- Development phase
- 4,152
- Enrollment target
NCT05657808: Completed NA study, sponsored by Radicle Science.
NCT05657808 is a NA study that has completed, run by Radicle Science. The registered enrollment target is 4,152 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (196% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05657808, a NA study, has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,152 participants
- Enrollment target
Study Summary
A randomized, blinded, placebo-controlled direct-to-consumer study assessing the impact of health and wellness products on sleep and other health outcomes.
Primary Outcome
Mean difference in sleep disturbance score as assessed by Patient Reported Outcome Measurement System (PROMIS) Sleep Disturbance Short Form 8A (scale 8-40; where higher scores correspond to greater sleep disturbance)
Interventions
- DIETARY_SUPPLEMENT Rest Study Active Product 1.1 Usage
- DIETARY_SUPPLEMENT Rest Study Active Product 1.2 Usage
- DIETARY_SUPPLEMENT Rest Study Active Product 2.1 Usage
- DIETARY_SUPPLEMENT Rest Study Active Product 2.2 Usage
- DIETARY_SUPPLEMENT Placebo Control Form 1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,152 participants |
| Start Date | 2023-01-09 |
| Est. Completion | 2024-04-15 |
| Phase | NA |
What the finished NCT05657808 record still lists
NCT05657808 is an interventional study that assigns participants to a tested intervention. Its 4,152 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (196% higher).
The record links to 0 conditions, and to 5 interventions - of which Rest Study Active Product 1.1 Usage is the first listed.
NCT05657808 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05657808 about?
NCT05657808 is a clinical study titled "Radicle Rest 2: A Study of Health and Wellness Products on Sleep and Health Outcomes". A randomized, blinded, placebo-controlled direct-to-consumer study assessing the impact of health and wellness products on sleep and other health outcomes.
What is the current status of trial NCT05657808?
This trial is currently completed. It is a NA study. The enrollment target is 4,152 participants. The study started on 2023-01-09. Estimated completion is 2024-04-15.
What interventions are being tested in trial NCT05657808?
The interventions under investigation include: Rest Study Active Product 1.1 Usage (DIETARY_SUPPLEMENT), Rest Study Active Product 1.2 Usage (DIETARY_SUPPLEMENT), Rest Study Active Product 2.1 Usage (DIETARY_SUPPLEMENT), Rest Study Active Product 2.2 Usage (DIETARY_SUPPLEMENT), Placebo Control Form 1 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05657808?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05657808's enrollment target sits among peer trials
4,152 32nd of 2000 higher than 1,969 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06593353 · 4,165 participants · NA
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
- NCT06935370 · 4,200 participants · Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI